• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

构建骨肉瘤的三维骨骼模型以研究癌症机制并评估治疗方法。

Developing a 3D bone model of osteosarcoma to investigate cancer mechanisms and evaluate treatments.

作者信息

Smith Hannah L, Beers Stephen A, Kanczler Janos M, Gray Juliet C

机构信息

Antibody and Vaccine Group, Faculty of Medicine, Centre for Cancer Immunology, School of Cancer Sciences, University of Southampton, Southampton, UK.

Bone and Joint Research Group, Human Development and Health, Faculty of Medicine, Institute of Developmental Sciences, University of Southampton, Southampton, UK.

出版信息

FASEB J. 2024 Dec 13;38(24):e70274. doi: 10.1096/fj.202402011R.

DOI:10.1096/fj.202402011R
PMID:39724514
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11670810/
Abstract

Osteosarcoma is the most common primary bone cancer, occurring frequently in children and young adults. Patients are treated with surgery and multi-agent chemotherapy, and despite the introduction of mifamurtide in 2011, there has been little improvement in survival for decades. 3-dimensional models offer the potential to understand the complexity of the osteosarcoma tumor microenvironment and aid in developing new treatment approaches. An osteosarcoma 3D bone core model was developed using human trabecular bone and the chorioallantoic membrane (CAM), to form a functioning vasculature. A tri-culture of cells, stromal cells, macrophages, and the Saos-2 osteosarcoma cell line, were implanted into this model to simulate components of the tumor microenvironment, and mifamurtide was tested in this context. Immunohistochemistry and micro-CT were performed to assess phenotypic and structural effects of implantation. Successful integration and angiogenesis of the bone cores were observed after incubation on the CAM. The 3D bone model also showed similar characteristics to osteosarcoma patient samples including CD68 and CD105 expression. Incubating bone cores with mifamurtide induced a reduction of cellular markers and an increase in bone volume. This 3D bone core model has the potential to investigate osteosarcoma tumor microenvironment and provides a representative model for evaluation of novel therapies.

摘要

骨肉瘤是最常见的原发性骨癌,在儿童和年轻人中频繁发生。患者接受手术和多药联合化疗,尽管2011年引入了米伐木肽,但几十年来生存率几乎没有改善。三维模型为理解骨肉瘤肿瘤微环境的复杂性以及开发新的治疗方法提供了可能。利用人松质骨和绒毛尿囊膜(CAM)构建了一个骨肉瘤三维骨芯模型,以形成功能性脉管系统。将细胞、基质细胞、巨噬细胞和Saos-2骨肉瘤细胞系进行共培养,植入该模型以模拟肿瘤微环境的组成部分,并在此背景下对米伐木肽进行了测试。进行免疫组织化学和显微CT以评估植入的表型和结构效应。在CAM上孵育后观察到骨芯的成功整合和血管生成。该三维骨模型还显示出与骨肉瘤患者样本相似的特征,包括CD68和CD105表达。用米伐木肽孵育骨芯可导致细胞标志物减少和骨体积增加。这种三维骨芯模型有潜力研究骨肉瘤肿瘤微环境,并为评估新疗法提供一个代表性模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04fc/11670810/d55f01d47e5c/FSB2-38-e70274-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04fc/11670810/9f01a3d23c29/FSB2-38-e70274-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04fc/11670810/13d9a7a1cd35/FSB2-38-e70274-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04fc/11670810/f9eff3ac70c5/FSB2-38-e70274-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04fc/11670810/a8b2015cbbf4/FSB2-38-e70274-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04fc/11670810/0761e26021ec/FSB2-38-e70274-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04fc/11670810/c7c98c06168f/FSB2-38-e70274-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04fc/11670810/d55f01d47e5c/FSB2-38-e70274-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04fc/11670810/9f01a3d23c29/FSB2-38-e70274-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04fc/11670810/13d9a7a1cd35/FSB2-38-e70274-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04fc/11670810/f9eff3ac70c5/FSB2-38-e70274-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04fc/11670810/a8b2015cbbf4/FSB2-38-e70274-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04fc/11670810/0761e26021ec/FSB2-38-e70274-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04fc/11670810/c7c98c06168f/FSB2-38-e70274-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04fc/11670810/d55f01d47e5c/FSB2-38-e70274-g008.jpg

相似文献

1
Developing a 3D bone model of osteosarcoma to investigate cancer mechanisms and evaluate treatments.构建骨肉瘤的三维骨骼模型以研究癌症机制并评估治疗方法。
FASEB J. 2024 Dec 13;38(24):e70274. doi: 10.1096/fj.202402011R.
2
Muramyl tripeptide (mifamurtide) for the treatment of osteosarcoma.用于治疗骨肉瘤的胞壁酰三肽(米伐木肽)。
Expert Rev Anticancer Ther. 2009 Aug;9(8):1035-49. doi: 10.1586/era.09.69.
3
The Role of Mifamurtide in Chemotherapy-induced Osteoporosis of Children with Osteosarcoma.米伐木肽在骨肉瘤患儿化疗性骨质疏松中的作用。
Curr Cancer Drug Targets. 2017;17(7):650-656. doi: 10.2174/1568009616666161215163426.
4
Long-Circulating and Targeted Liposomes Co-loading Cisplatin and Mifamurtide: Formulation and Delivery in Osteosarcoma Cells.长循环靶向脂质体共载顺铂和米伐木肽:骨肉瘤细胞中的制剂与递送。
AAPS PharmSciTech. 2024 Nov 26;25(8):272. doi: 10.1208/s12249-024-02992-7.
5
Mifamurtide in metastatic and recurrent osteosarcoma: a patient access study with pharmacokinetic, pharmacodynamic, and safety assessments.转移性和复发性骨肉瘤中的米伐木肽:一项具有药代动力学、药效学和安全性评估的患者准入研究。
Pediatr Blood Cancer. 2014 Feb;61(2):238-44. doi: 10.1002/pbc.24686. Epub 2013 Aug 31.
6
Mifamurtide: a review of its use in the treatment of osteosarcoma.米伐木肽:用于治疗骨肉瘤的综述。
Paediatr Drugs. 2010 Jun;12(3):141-53. doi: 10.2165/11204910-000000000-00000.
7
Mifamurtide in osteosarcoma--a practical review.米法莫肽治疗骨肉瘤——实用综述
Drugs Today (Barc). 2010 May;46(5):327-37. doi: 10.1358/dot.2010.46.5.1500076.
8
The addition of the immunomodulator mifamurtide to adjuvant chemotherapy for early osteosarcoma: a retrospective analysis.在早期骨肉瘤辅助化疗中添加免疫调节剂米伐木肽的回顾性分析。
Invest New Drugs. 2022 Jun;40(3):668-675. doi: 10.1007/s10637-022-01225-7. Epub 2022 Mar 21.
9
Orphan drugs revisited: cost-effectiveness analysis of the addition of mifamurtide to the conventional treatment of osteosarcoma.再谈孤儿药:米法穆肽添加至骨肉瘤常规治疗中的成本效益分析
Expert Rev Pharmacoecon Outcomes Res. 2015 Apr;15(2):331-40. doi: 10.1586/14737167.2015.972378. Epub 2014 Oct 29.
10
Effectiveness of mifamurtide in addition to standard chemotherapy for high-grade osteosarcoma: a systematic review.米法木肽联合标准化疗治疗高级别骨肉瘤的有效性:一项系统评价
JBI Database System Rev Implement Rep. 2017 Aug;15(8):2113-2152. doi: 10.11124/JBISRIR-2016-003105.

本文引用的文献

1
3D Tumor-Engineered Model Replicating the Osteosarcoma Stem Cell Niche and Tumor Complexity.复制骨肉瘤干细胞微环境和肿瘤复杂性的3D肿瘤工程模型
ACS Appl Mater Interfaces. 2024 Oct 1;16(41):55011-26. doi: 10.1021/acsami.4c02567.
2
Tri-Lineage Differentiation Potential of Osteosarcoma Cell Lines and Human Bone Marrow Stromal Cells from Different Anatomical Locations.不同解剖部位骨肉瘤细胞系和人骨髓基质细胞的三系分化潜能。
Int J Mol Sci. 2023 Feb 11;24(4):3667. doi: 10.3390/ijms24043667.
3
Analysis of prognostic factors and histopathological response to neoadjuvant chemotherapy in osteosarcoma.
骨肉瘤新辅助化疗的预后因素及组织病理学反应分析。
Jt Dis Relat Surg. 2023;34(1):196-206. doi: 10.52312/jdrs.2023.902. Epub 2023 Jan 14.
4
Targeted alpha therapy with the Ra/Pb-TCMC-TP-3 dual alpha solution in a multicellular tumor spheroid model of osteosarcoma.在骨肉瘤多细胞肿瘤球体模型中使用Ra/Pb-TCMC-TP-3双α溶液进行靶向α治疗。
Front Med (Lausanne). 2022 Nov 23;9:1058863. doi: 10.3389/fmed.2022.1058863. eCollection 2022.
5
Bone marrow and periosteal skeletal stem/progenitor cells make distinct contributions to bone maintenance and repair.骨髓和骨膜骨骼干细胞/祖细胞对骨骼维持和修复有不同的贡献。
Cell Stem Cell. 2022 Nov 3;29(11):1547-1561.e6. doi: 10.1016/j.stem.2022.10.002. Epub 2022 Oct 21.
6
Anti-EGFR Targeted Multifunctional I-131 Radio-Nanotherapeutic for Treating Osteosarcoma: In Vitro 3D Tumor Spheroid Model.用于治疗骨肉瘤的抗表皮生长因子受体靶向多功能碘-131放射性纳米疗法:体外3D肿瘤球体模型
Nanomaterials (Basel). 2022 Oct 8;12(19):3517. doi: 10.3390/nano12193517.
7
Engineering Novel 3D Models to Recreate High-Grade Osteosarcoma and its Immune and Extracellular Matrix Microenvironment.工程化新型 3D 模型以重现高级别骨肉瘤及其免疫和细胞外基质微环境。
Adv Healthc Mater. 2022 Oct;11(19):e2200195. doi: 10.1002/adhm.202200195. Epub 2022 Sep 4.
8
An Osteosarcoma Model by 3D Printed Polyurethane Scaffold and In Vitro Generated Bone Extracellular Matrix.一种通过3D打印聚氨酯支架和体外生成的骨细胞外基质构建的骨肉瘤模型。
Cancers (Basel). 2022 Apr 15;14(8):2003. doi: 10.3390/cancers14082003.
9
Multi-omics analysis based on 3D-bioprinted models innovates therapeutic target discovery of osteosarcoma.基于3D生物打印模型的多组学分析创新了骨肉瘤治疗靶点的发现。
Bioact Mater. 2022 Mar 29;18:459-470. doi: 10.1016/j.bioactmat.2022.03.029. eCollection 2022 Dec.
10
HIF activation enhances FcγRIIb expression on mononuclear phagocytes impeding tumor targeting antibody immunotherapy.缺氧诱导因子(HIF)的激活增强单核吞噬细胞上 FcγRIIb 的表达,从而阻碍肿瘤靶向抗体免疫治疗。
J Exp Clin Cancer Res. 2022 Apr 7;41(1):131. doi: 10.1186/s13046-022-02294-5.